{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Effects of Dexmedetomidine on Postoperative Recovery in Elderly TKA Patients: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned in a 1:1:1 ratio"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a tertiary hospital in China, this single-center, randomised controlled trial enrolled 225 patients aged 60 years or older undergoing elective TKA"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned in a 1:1:1 ratio to receive 0.6 \u03bcg/kg/h dexmedetomidine (Group D2), 0.3 \u03bcg/kg/h dexmedetomidine (Group D1), or saline (Group N)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to assess the impact of dexmedetomidine on postoperative quality of recovery (QoR) in elderly patients undergoing total knee arthroplasty (TKA)"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the QoR-15 score on postoperative day 1"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using a computer-generated sequence, and allocation was concealed"
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was maintained for patients, clinicians, and outcome assessors"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "this single-center, randomised controlled trial enrolled 225 patients aged 60 years or older undergoing elective TKA between December 2022 and June 2023"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of the 225 patients, 204 were included in the analysis"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Group D2 demonstrated a significant improvement in QoR-15 scores on postoperative day 1 compared to Group N (median difference, 6 points; 95% CI, 4 to 8; P < 0.001) and Group D1 (median difference, 4 points; 95% CI, 2 to 5; P = 0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were similar across groups, with no significant differences in hypotension or bradycardia"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ChiCTR2200066337"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 23,
    "max_score": 25
  },
  "model": "gpt-4o"
}